WallStreetZenWallStreetZen

NASDAQ: PCSA
Processa Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their PCSA stock forecasts and price targets.

Forecast return on equity

Is PCSA forecast to generate an efficient return?

Company
-727.9%
Industry
-15.03%
Market
47.86%
PCSA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PCSA forecast to generate an efficient return on assets?

Company
-533.73%
Industry
-1.27%
PCSA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PCSA earnings per share forecast

What is PCSA's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$2.16

PCSA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PCSA$0.26N/AN/A
PALI$0.64$16.00+2,400.00%Strong Buy
LIXT$1.14N/AN/A
INM$2.53N/AN/A
ZVSA$0.65N/AN/A
View Top Biotech Stocks

Processa Pharmaceuticals Stock Forecast FAQ

What is PCSA's earnings growth forecast for 2025-2025?

(NASDAQ: PCSA) Processa Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Processa Pharmaceuticals's earnings in 2025 is -$11,958,142.

In 2025, PCSA is forecast to generate -$25,670,209 in earnings, with the lowest earnings forecast at -$25,670,209 and the highest earnings forecast at -$25,670,209.

If you're new to stock investing, here's how to buy Processa Pharmaceuticals stock.

What is PCSA's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: PCSA) forecast ROE is -727.9%, which is considered weak.

What is PCSA's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: PCSA) Processa Pharmaceuticals's current Earnings Per Share (EPS) is -$3.08. In 2025, PCSA's EPS is forecast to hit -$2.16 (min: -$2.16, max: -$2.16).

What is PCSA's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: PCSA) forecast ROA is -533.73%, which is lower than the forecast US Biotechnology industry average of -1.27%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.